Home › FDA OKs Merck hepatitis C drug, adding to patient choices
 

Keywords :   


FDA OKs Merck hepatitis C drug, adding to patient choices

2016-01-29 02:48:54| Biotech - Topix.net

Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. The combination pill includes the medications elbasvir and grazoprevir, which attack the virus in two different ways.

Tags: drug adding patient choices

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Croda Beauty Launches New Ceramide Range
16.05Doves New Bond Strength Range Contains Proprietary Bio-Protein Care and Peptides
16.05Mount Sinai Awarded $6.6 Million from National Institutes of Health to Investigate Treatment ...
16.05Eastern North Pacific Tropical Weather Outlook
16.05Amherst Label adds third Domino press
16.05Atlantic Tropical Weather Outlook
16.05Simply.TV provides metadata to Drei TV Austria
16.05Backlash as Morrisons trials sale of New Zealand lamb
More »